English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [847]
News [2149]
Articles [24]
Editorials [1]
Conferences [133]
elearning [2]
Personalised simulations predict patient outcomes for blood cancer treatment in breakthrough study
Personalised simulations predict patient outcomes for blood cancer treatment in breakthrough study
Microproteins found in tumours could lead to cancer vaccines
Microproteins found in tumours could lead to cancer vaccines
A new proteogenomics analysis of high-grade gliomas offers hints on tumour evolution
A new proteogenomics analysis of high-grade gliomas offers hints on tumour evolution
RNAs may help identify stage II colon cancer patients who may benefit from chemotherapy following surgery
RNAs may help identify stage II colon cancer patients who may benefit from chemotherapy following surgery
Re-engineering cancerous tumours to self-destruct and kill drug-resistant cells
Re-engineering cancerous tumours to self-destruct and kill drug-resistant cells
One bad apple spoils the barrel: New study uncovers multiple molecular subgroups in liver cancer with most aggressive driving clinical outcomes
One bad apple spoils the barrel: New study uncovers multiple molecular subgroups in liver cancer with most...
Inherited genetic factors may predict the pattern of X chromosome loss in older women
Inherited genetic factors may predict the pattern of X chromosome loss in older women
Evidence-based recommendations published for tumour mutational burden testing
Evidence-based recommendations published for tumour mutational burden testing
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test
ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower risk
ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower...
<1…1213141516…215>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top